Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
نویسندگان
چکیده
منابع مشابه
Why Thailand should consider promoting neonatal circumcision?
Male circumcision (MC) has been proven to reduce the risk of HIV transmission. The WHO and UNAIDS jointly recommend the international community consider MC as an HIV prevention measure. MC reduces the risk of acquiring other sexually transmitted infections (STIs) among men, urinary tract infections among children and penile cancer. Lowering the prevalence of STIs in men may reduce the incidence...
متن کاملWhy Engineers Should Consider Formal Methods
This paper presents a logical analysis of a typical argument favoring the use of formal methods for software development, and suggests an alternative argument that is simpler and stronger than the typical one.
متن کاملShould benefit–risk assessment have its own drug “label”?
Many consumers and clinicians incorrectly believe that the Food and Drug Administration (FDA) approval of a new therapeutic implies that its benefits have been proven to exceed its harms. While the FDA could require proof that benefits exceed harms prior to approval, it has been argued that this approach would be infeasible because of prohibitively large sample sizes. One possible alternative w...
متن کاملPhysical health promotion in people with schizophrenia: why we should consider the ultra high-risk state.
1. Balon R. Politics of self-citation. Acta Psychiatr Scand 2015;132:165. 2. Wakefield JC. The editor’s dilemma: how DSM politics are turning psychiatry into pseudoscience. Acta Psychiatr Scand 2015;132:425–426. 3. Balon R, Richard Balon CV. http://www.experts.scival. com/wayneresearchconnect/printpage_cv_ctrl.asp?n=Rich ard+Balon&u_id=53&oe_id=1&o_id=14. Accessed 10 January 2015. 4. Wakefield ...
متن کاملWhy should cardiologists consider genetic testing for hypertrophic cardiomyopathy?
A lthough it has been more than a decade since the official announcement of the complete sequencing of the human genome, the impact of this monumental achievement on clinical practice has so far fallen short of expectations. Many thought that medicine in the “post-genome era” would quickly develop into highly personalized care, with targeted therapies based on individual mutations. Impatient cr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PharmacoEconomics
سال: 2013
ISSN: 1170-7690,1179-2027
DOI: 10.1007/s40273-013-0118-6